Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Nasopharyngeal Carcinoma 2Carcinoma, Hepatocellular 2Pancreatic Neoplasms 1

Interventions

Sorafenib 29Nivolumab 15pembrolizumab 12Radiosurgery 9Bevacizumab 9atezolizumab 7regorafenib 5Radiotherapy 5Fluorouracil 5Doxorubicin 5lenvatinib 4Sunitinib 4Oxaliplatin 4Ipilimumab 4Gemcitabine 4Ethiodized Oil 4Erlotinib Hydrochloride 4Capecitabine 4TLC 388 3Radiofrequency Ablation 3Leucovorin 3Everolimus 3Cisplatin 3Blood Specimen Collection 3toripalimab 2phosphomannopentaose sulfate 2durvalumab 2cediranib 2avelumab 2Tirapazamine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Carcinoma, Hepatocellular × Heavy Ion Radiotherapy × Clear all
NCT02802124 2023-12-07

Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular Carcinoma

Shanghai Proton and Heavy Ion Center

Phase NA Terminated
30 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01167374 2022-11-03

PROMETHEUS-01

University Hospital Heidelberg

Phase NA Terminated
21 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡